chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Intense period pains and cramps, much worse than I have ever experienced, during my period following the vaccination.
ask if it is okay to take antibiotics prescribed by her Urologist for possible bladder infection; This is a spontaneous report from a Pfizer-sponsored program Pfizer Covax US Support. A contactable Female consumer (Patient) of unspecified age reported that she received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration on 05Feb2021 (Batch/Lot number was not reported) as DOSE 1, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. It was reported that patient asked if it is okay to take antibiotics prescribed by her urologist for possible bladder infection before the schedule of her second dose for Covid-19 vaccine on 26Feb2021. The outcome of the event was unknown.   Information on the lot/batch number has been requested.  Follow-up attempts completed. No further information expected.
Pt received H1N1 vaccine on 12/8/09 at school. On 12/9/09 pt developed nausea, low grade temp S/T, HA & joint pains.
Got shots still got shingles/suspected vaccination failure; Shingles; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: Got shots still got shingles/suspected vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: Shingles). The outcome of the vaccination failure was unknown and the outcome of the shingles was not reported.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     It was unknown if the company considered the vaccination failure and shingles to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 09-MAR-2023 This case was reported by a patient via interactive digital media. The reporter reported that one of his/her friend received Shingles vaccine but still experienced shingles. This case was considered as suspected vaccination failure as details regarding completion of primary schedule, time to onset for shingles and laboratory confirmation regarding shingles were unknown at the time of reporting. Follow-up would not possible as no contact details were available.
* Pain at injection site                              *SX persisted for 2-3 days * Flu-like sx: low grade fever fatigue *tenderness/redness around lymph node at collar bone
Exp date Vaccines went into 2-8 C thaw state on or about 24-Dec-2021; Received vaccine past its 30-days; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received vaccine past its 30-days) and PRODUCT STORAGE ERROR (Exp date Vaccines went into 2-8 C thaw state on or about 24-Dec-2021) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Feb-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 02-Feb-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received vaccine past its 30-days). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Exp date Vaccines went into 2-8 C thaw state on or about 24-Dec-2021). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Received vaccine past its 30-days) and PRODUCT STORAGE ERROR (Exp date Vaccines went into 2-8 C thaw state on or about 24-Dec-2021) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant medication reported  The ethnicity of the patient was given. No Treatment medication reported
In the evening of the fourth day after the vaccination (wednesday)  the patient started feeling dizziness and lightheadedness.   She was bed bound due to the dizziness thurs and friday night.   Had it over the weekend as well.  Felt a little better Monday and drove to work but experienced enough dizziness that she felt unsafe even driving and went back home.
Fatigue 3/14/21 9am through 3/17/21 9am Fever up to 102.9 began 3/14/21 and went through 3/15/21 7am Chills, was very cold, shivering from 3/14/21 11am through 3/15/21 5am  Muscle aches 3/14/21 11am through 3/15/21 7pm Weakness 3/14/21 10am through 3/15/21 7am Anxious 3/14/21 1pm through 3/15/21 7am Worried 3/14/21 1pm through 3/15/21 7am Tired 3/14/21 10am through 3/15/21 7am
Local reaction 3-4 cm redness, induration, heat, pain at 48 hours.
Information has been received from a physician concerning a 5-month-old female who on 04-DEC-2006 was vaccinated with the first dose of rotavirus reassortant vaccine live. Unspecified medical attention was sought and no symptoms were reported.  Additional information has been requested.
Narrative:  pt died within 42 days of rec vaccine - unknown med administer , pt at an outside hospital
6/21 - Had a fever and tremors that started roughly 12 hours after injection that went away overnight 6/22 - Felt tired and achey all over, little appetite.  Went away after this day 6/23 - Felt fine until roughly 10pm,  began to experience chest pain in hand sized area centered on sternum 6/24 - Chest pain continues and any significant activity causes slight shortness of breath
Expired dose administered; This case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a 15-month-old male patient who received DTPa (Infanrix) (batch number 5RM39, expiry date 25th November 2022) for prophylaxis.   Co-suspect products included dtpa vaccine pre-filled syringe device (Infanrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 6th December 2022, the patient received Infanrix and Infanrix Pre-Filled Syringe Device. On an unknown date, unknown after receiving Infanrix and Infanrix Pre-Filled Syringe Device, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.     This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 07-DEC-2022 Reporter's Comments: Registered Nurse called to inquire if any harm to patient or was this dose valid. The reporter also inquired would the patient need to be revaccinated. The reporter reported in their facility, they inadvertently administered Infanrix on 6th December 2022, which was expired on 25th November 2022. The reporter did not consent to follow-up. Additional Supportive Information: the patient received vaccine, which was already expired on 25th November 2022, which led to expired vaccine administered.
Headaches - starting 10 minutes after vaccine.  Increased heart rate.  Difficulty breathing.  Glands swelled.  Scalp burning - hair falling out.
Receipt of typhoid and Anthrax vaccine #1 22 March 2007 and AVA #2 on April 5, 2007. She c/o sore throat x 1 wk after AVA #1, no problems with AVA. Pregnancy test during routine deployment screening 4/19/2007 identified positive pregnancy test with bHCG of 8500 on 21 April 2007. Normal delivery 14 Dec 2007. Child with "snorty breathing" x 2 months otherwise healthy.
Administered only the diluent; Administered only the diluent; This non-serious case was reported by a nurse via call center representative and described the occurrence of inappropriate preparation of medication in a 16-year-old male patient who received Men ACWY-CRM NVS (Menveo) (batch number AMXA764A, expiry date 30-SEP-2024) for prophylaxis.   On 28-MAR-2023, the patient received Menveo. On 28-MAR-2023, an unknown time after receiving Menveo, the patient experienced inappropriate preparation of medication (Verbatim: Administered only the diluent) and inappropriate dose of vaccine administered (Verbatim: Administered only the diluent). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.   Additional Information: GSK Receipt Date: 30-MAR-2023 The reporter called to inquire to know if any information on how to proceed an what to look for with patient. The reporter reported that they inadvertently administered the Menveo diluent component without the Menveo lyophilized component to a patient. The reporter did not consent to follow-up. The reporter reported that they inadvertently administered the Menveo diluent component without the Menveo lyophilized component to a patient, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered.
INSTANCES SOB; NAUSEA; LOW-GRADE FEVER; LOW GFR; This spontaneous report received from a patient concerned a 72 year old female. The patient's weight was 186 pounds, and height was 64 inches. The patient's past medical history included: depression, and anxiety, and concurrent conditions included: chronic kidney disease (ckd), hypertension (htn), thyroid condition, gerd, grass allergy, mold allergy, pet dander allergy, dust allergy, non alcohol user, and non smoker, and other pre-existing medical conditions included: The patient had no drug abuse or illicit use. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1820095, and expiry: 18-AUG-2021) dose was not reported, administered on 21-JUL-2021 for prophylactic vaccination. Concomitant medications included clonazepam for drug used for unknown indication, famotidine for drug used for unknown indication, fluoxetine for drug used for unknown indication, hydralazine for drug used for unknown indication, lamotrigine for drug used for unknown indication, levothyroxine for drug used for unknown indication, and liothyronine for drug used for unknown indication. On 26-JUL-2021, the patient experienced low gfr. Laboratory data included: GFR (NR: not provided) 15. On an unspecified date, the patient experienced instances sob, nausea, and low-grade fever. Laboratory data (dates unspecified) included: GFR (NR: not provided) 20, 16. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from low gfr, and the outcome of instances sob, nausea and low-grade fever was not reported. This report was non-serious.
I received the FLUCELVAX vaccine by injection on Jan 10, 2014. Early in the morning on Jan 11, 2014, I awoke to severe musculoskeletal pain, headache, and sweating. Throughout Jan 11, 2014, I continued to experience severe musculoskeletal pain throughout my body and had a low-grade fever.
around October or November high blood pressure/ highest recorded was 189/122 and the lowest 127/74, average of 156/104; She was in pain; This spontaneous case was reported by an other health care professional and describes the occurrence of HYPERTENSION (around October or November high blood pressure/ highest recorded was 189/122 and the lowest 127/74, average of 156/104) and PAIN (She was in pain) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 088B21A and 088B21A) for COVID-19 vaccination.     The patient's past medical history included Suspected COVID-19 (Fever, sweat, cold, diarrhea and lost 20 pounds) in June 2020. Family history included Hypertension (has a history of high blood pressure in the family but patient never got it before.) since an unknown date. Concurrent medical conditions included Migraine. Concomitant products included ASPIRIN [ACETYLSALICYLIC ACID] for an unknown indication.   On 08-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Sep-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced HYPERTENSION (around October or November high blood pressure/ highest recorded was 189/122 and the lowest 127/74, average of 156/104) and PAIN (She was in pain). At the time of the report, HYPERTENSION (around October or November high blood pressure/ highest recorded was 189/122 and the lowest 127/74, average of 156/104) had not resolved and PAIN (She was in pain) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood pressure measurement: 189/122 (High) Her highest recorded was 189/122, 127/74 the lowest 127/74 and 156/104 (High) in an average of 156/104. On an unknown date, SARS-CoV-2 test: negative (Negative) COVID-19 test came back negative.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication information provided also included that the patient was taking allergy and migraine medicine.  The reporter who was an HCP stated that they started to notice around October or November that the patient had high blood pressure. The patient was in pain because of it and started to monitor it in December. The patient repeated several times that it shouldn't be like this: shouldn't be so bizarre.  Before getting the vaccine, the patient would tend towards the lower range of 99/60. It was also reported that the patient had no allergies. The patient also had a history of high blood pressure in the family, but the patient never got it before. The patient also mentioned a lot of previous medical problems (before the vaccine) like migraines and was frequently visiting their cardiologist, neurologist, and gastroenterologist.   The patient's height reported as 5 feet 2 inch.  As a treatment medication, the patient received myosin complex and did not wanted to get blood pressure medication.   This case was linked to MOD-2022-485292 (Patient Link).
sick with something; Initial information was received on 12-Dec-2020 regarding an unsolicited valid non-serious social media case from a consumer.  This case  was linked with 2020SA358166 (same reporter).  This case involves female patient (unknown age) who sick with something (Illness), while she received INFLUENZA VACCINE.  Medical history, medical treatment(s), concomitant medications, vaccination(s) and family history were not provided.  On an unknown date in September 2019, the patient received a dose of suspect influenza vaccine produced by unknown manufacturer (lot number and expiry date not reported) via unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date in November 2019, the patient experienced sick with something (Illness), (unknown latency) following the administration of influenza vaccine.  It was reported that, the reporter had question about if the flu shot works then why did they get sick or was it the new virus COVID19.  No laboratory data was provided.  It was not reported if the patient received any corrective treatment.  At the time of reporting, the outcome was unknown for the event.  There will be no information available on batch number for this case.
pt arm swelled up to twice the size as the other arm, pt had red splotches on arm and it was hot and warm.  Lasted several days. Pt was also ill, body aches and upset stomach. Pt had same reaction to influenza vaccine in 2018
Immediately feeling ill. Pain to the site that increased over the next week. Pain persisted for several weeks. Febrile T max unknown, Fatigued for several days. Spent several days in bed.  Hyper pigmentation at the injection site began after several days and she still has it.
Heard strange cry. Mother found child around 11:00pm, 5-26-08 having seizure, eyes rolled back, clonic, generalized (E.R. Report). Parents called 911. Lasted 1-2 minutes; Fever 102 - later increased to 104. Glucose 90 is field. Chest XRay and urinalysis in ER; Bilateral patchy appeared normal in ER. Infiltrate on XRay. UA - Normal - Diagnosed Febrile seizure.
Headache within three hours post vaccination.  The headache was severe and lasted 6 weeks.  Once the headache resolved, episodes of tachycardia, frequent heart palpitations that brought me to the ER, and vision changes occurred.  One month later, a Holter test revealed frequent palpitations unrelated to cardiac injury.  At the same time, the vision impairment progressed to pixelated or static visual field, and I was diagnosed in October with Visual Snow Syndrome.  Currently, the visual snow syndrome persists, and in March of 2022, I began developing widespread numbness, tingling, and burning. In all extremities, my face, my scalp.  This persists during my current report in July 2022.  My hair is also falling out and my health status feels ?off? - fatigue, feeling low, aches.  Before my vaccination in 2021, I was an athlete, healthy eater, and very positive.  Since getting the second vaccination, my life has changed.
PROQUAD was inadvertently administered instead of MMR II.; No reported adverse affects.; Information has been received from a nurse referring to a patient of unknown age and gender. Information of concomitant therapy, pertinent medical history and drug reactions/allergies was not reported.  On an unknown date, the patient was inadvertently vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD)(lot # R011803, expiration date: 21-OCT-2019, therapy type: recombinant Human albumin (rHA); strength, dose and frequency were unknown) subcutaneously instead of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II)(strength, dose, frequency, route, lot# and expiration date were unknown) for prophylaxis (wrong vaccine administered). No reported adverse affects. The nurse confirmed that this was "human error".
Fever, chills, fatigue, body aches, headache, nausea the entire next day
Information has been received from a physician concerning a 63 year old male with no known drug allergies, and with coronary artery disease, chronic obstructive pulmonary disease, and hypertension, and a history of coronary artery bypass surgery and cardiac pacemaker insertion. It was noted that the patient was in the hospital for the unrelated event of angina when on 2/21/05 when was vaccinated in the right tricep with a dose of pneumococcal 23v polysaccharide vaccine (lot # 649978/0709P). Concomitant therapy included sodium folate, aspirin, acetaminophen, temazepam, lovastatin, enalapril maleate, carvedilol, digoxin, and propranolol HCl. On 2/21/05, approximately 50 minutes post vaccination, the patient developed pain, redness, and swelling from his tricep to his elbow, a temperature of 101, and a white blood cell count of 25,000. He was diagnosed with presumptive cellulitis. He was treated with IV antibiotics. At the time of the report, it was noted that he almost fully recovered. There was no product quality complaint. Follow up information indicated that the patient was hospitalized due to an underlying cardiac disease. He also stated that the patient had improved clinically after therapy with IV vancomycin. The physician indicated that the last time he saw the patient, the cellulitis was almost completely gone. He did not feel that the cellulitis was life-threatening or a cause of disability. The physician stated that he had signed off this patient's case and had no further information. The reporter indicated that the event was an other important medical event (OMIC). No additional information is expected.
Rapid heart beat after the first shot; Not sure if it was anxiety after the first shot; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of HEART RATE INCREASED (Rapid heart beat after the first shot) and ANXIETY (Not sure if it was anxiety after the first shot) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In 2021, the patient experienced HEART RATE INCREASED (Rapid heart beat after the first shot) and ANXIETY (Not sure if it was anxiety after the first shot). In 2021, HEART RATE INCREASED (Rapid heart beat after the first shot) and ANXIETY (Not sure if it was anxiety after the first shot) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided. No treatment provided. Patient states that she is terrified of getting the second dose.
This spontaneous report as received from a nurse. She states that doses of MMR II and ROTATEQ that were exposed to 50F for 48 hours were administered to patients. The patients were vaccinated with MMR II. Other suspect therapies included ROTATEQ. No concomitant medications were reported. On an unknown date the patient experienced doses of MMR II and ROTATEQ that were exposed to 50F for 48 hours were administered to patients. No treatment information was reported. Doses of MMR II and ROTATEQ that were exposed to 50F for 48 hours were administered to patients is not related to MMR II nd ROTATEQ. At the time of the call, she does not know who received the doses of improperly stored vaccine, but she would like to know if they should be revaccinated. She will call to provide details when she is able to retrieve the information. SR # provided. It is not known at this time if there have been any adverse effects. 13Nov2012 Additional information received: MMR vaccine Date given 11/01/2012. Lot # 1571AA. Additional information has been requested.
It appears this patient has received a 3rd bivalent booster dose almost a month after receiving a 2nd bivalent booster dose.
Pain in the arm he got the shot; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain in the arm he got the shot) in a 51-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 21-Mar-2021, the patient experienced PAIN IN EXTREMITY (Pain in the arm he got the shot). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (Pain in the arm he got the shot) had not resolved.            No concomitant medications were reported.  Treatment medications included heating pad, anti-inflammatory medications.  Action taken with mRNA-1273 in response to the events was not Applicable.
stomach ache; fever that peaked at 101.7°F; This spontaneous case was reported by a consumer and describes the occurrence of   in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient was treated with IBUPROFEN at an unspecified dose and frequency.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 01-Mar-2021, Pyrexia: 101.7 (High) Patient experienced 101.7 degrees Fahrenheit.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.